The Bioterrorism Act

January 2, 2004

Arthur J. Falk, PhD, is president and CDO of International Pharmaceutical Excipient Auditing (IPEA).

Pharmaceutical Technology, Pharmaceutical Technology-01-02-2004, Volume 28, Issue 1

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.